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Abstract
Motivation: An intuitive graphical interface that allows statistical analyses and visualizations
of extensive data without any knowledge of dedicated statistical software or programming.
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Implementation: EpiMetal is a single-page web application written in JavaScript, to be
used via a modern desktop web browser.
General features: Standard epidemiological analyses and self-organizing maps for data-
driven metabolic profiling are included. Multiple extensive datasets with an arbitrary
number of continuous and category variables can be integrated with the software. Any
snapshot of the analyses can be saved and shared with others via a www-link. We dem-
onstrate the usage of EpiMetal using pilot data with over 500 quantitative molecular
measures for each sample as well as in two large-scale epidemiological cohorts
(N>10 000).
Availability: The software usage exemplar and the pilot data are open access online at
[http://EpiMetal.computationalmedicine.fi]. MIT licensed source code is available at the
Github repository at [https://github.com/amergin/epimetal].
Introduction
We are living in a multi-omics era of systems epidemiol-
ogy.1,2 Quantitative high-throughput metabolomics3–6 and
lipidomics7,8 have resulted in hundreds of molecular meas-
ures for up to tens of thousands of people in multiple
cohorts and biobanks. Extensive and complex data create
significant challenges for statistical analyses. It would
therefore be beneficial, not only for omics beginners but
for all epidemiologists, to have a simple visual tool for
rapid exploratory analyses of these kinds of modern data-
sets without the immediate need of bioinformaticians flu-
ent with currently available professional statistical analysis
tools as, for example, the R software.9
To this end, we developed a web browser-based
graphical software—EpiMetal—for standard statistical
epidemiological analyses as well as for multivariate self-
organizing maps (SOMs) for data-driven analyses,
metabolic profiling and potentially for clinical sub-
grouping.10–15 EpiMetal is versatile and any dataset
with an arbitrary number of continuous and categorical
variables can be easily integrated with the software.
Data from multiple cohorts can be imported for com-
parative analyses. The original datasets can be divided
into subgroups via multiple ways, for example based on
SOMs, histograms or scatterplots; the created sub-
groups can be saved and analysed separately or in com-
parison with any other dataset. Regression analyses
with covariate adjustments are available with graphical
visualization of the results. Publication quality visual-
izations can be made and exported. Any snapshot of the
analyses pipeline can be saved and shared with others
via a www-link. Though it might not be an optimal
choice to use EpiMetal for final publishable results, an
additional good usage might be to use it as a bench-
marking tool for newly written scripts and functions in
another software.
As a usage exemplar, we present explorative analyses in
a pilot cohort of 190 samples16–18 for which serum nuclear
magnetic resonance (NMR) metabolomics3–6 and mass
spectrometry (MS) lipidomics8,19 data are available. The
data include over 500 quantitative molecular measures for
each individual from these complementary methodologies
that are getting increasingly popular in epidemiological
applications. This is apparently the first time these compre-
hensive data are combined in an epidemiological setting.
The data are made public along with the software (https://
github.com/amergin/epimetal/blob/master/python-api/api-
docker/samples.tsv). The exemplar demonstrates how the
graphical interface of EpiMetal can be used to visualize ex-
tensive data, select subgroups and ultimately gain epidemi-
ological insights via a combination of various statistical
analysis options. In the supplement we also illustrate com-
parative analyses for two large-scale epidemiological
cohorts.
Implementation
EpiMetal consists of three major components: (i) the data-
base (MongoDB) is the long-term store for dataset sam-
ples, computational results and stored sessions; (ii) a
single-page web application written in JavaScript (JS) that
is accessed by users via a web browser; and (iii) a back-end
software written in Python that serves as an intermediary
between the web application and the database to retrieve
data and record user sessions. The application uses third-
party open-source libraries (versions and licensing
information is available at Github). The software is encap-
sulated inside Docker containers to facilitate easy deploy-
ment across server platforms and to isolate the software
from host system. Several Plotter instances can be run in
parallel with differing configurations and data. The overall
architecture of the software is presented in Supplementary
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Figure 1. Key data handling, visualization and statistical analyses features of the EpiMetal software illustrated using real epidemiological data (Northern
Finland Birth Cohort 1966; N¼ 5713). A generalized flow of analysis begins by choosing a dataset(s) from user-uploaded options. This can be, for exam-
ple, one population cohort but also a combination of many. Main analysis options are located in the top of the graphical interface and divided into three
categories: ‘Explore and filter’, ‘Regression analysis’ and ‘SOM’. Under ‘Explore and filter’, the user can quickly generate basic plots to gain an overview
of the data structure. Variables can be plotted and compared using histograms, scatterplots and boxplots. Heatmaps can also be created for an overall vi-
sualization of variable Spearman’s rank correlations. Active filters can also be applied to select subsets of the data. For example, one can choose to ana-
lyse only individuals with HDL-C<1.0mmol/L in a given population cohort. The main category ‘Regression analysis’ allows the user to choose an
outcome and exposure variables with an optional number of covariates and to generate a forest plot displaying the point estimate and 95% confidence
intervals. Under ‘SOM’, the user can calculate a self-organizing map trained according to selected variables. The map can then be used to choose a subset
of the entire dataset on the basis of this metabolic profiling. It should be noted that the analyses made in the ‘Explore and filter’ and ‘SOM’ sections are
fully compatible with each other, enabling, for example, the SOM-based subgroups to be analysed via histograms and vice versa.
International Journal of Epidemiology, 2020, Vol. 0, No. 0 3
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyz244/5707356 by U
niversity of Bristol Library user on 04 February 2020
Figure S1, available as Supplementary data at IJE online.
Key data handling, visualization and statistical analyses
features are summarized in Figure 1.
Installation
A step-by-step installation guide is provided in the
EpiMetal software user guide. The source data are
imported from a machine-readable format file (usually a
tab-separated .tsv- or comma-separated values .csv-files)
where each row corresponds to an individual sample.
These samples have a unique identifier and usually belong
to a single dataset. An import configuration file defines the
column names and the column separator. A metadata file
is needed for the source data to indicate variable name,
free description, unit of measurement (e.g. mmol/L) and
the group name for each variable. For variables that follow
a common pattern, a regular expression pattern can be
employed. Imported variable types are either numerical or
categorical. Example files for the sample data are provided
in the Github repository. There is no hard limit for the
number of samples or variables that can be imported to the
software, but the larger the dataset, the longer the down-
load and processing times. The software has been tested
with over 500 variables and some 30 000 samples, which
present a realistic upper bound for current usage.
During the installation phase, a Docker container is set up
that initializes the database from the source data file, along
with the metadata descriptions. A second container is used
for compiling the front-end application from the JS source
files, forming a bundle. This container contains an http server
to serve the bundle to user’s web browser. A third container
runs the back end and its application programmatic interface
(API). Using the Docker system, the EpiMetal software can
be set up to serve an individual user locally, or to allow the
software to be accessed by the public. An example configura-
tion on how to limit the access to the software instance with
a user name and a password is provided.
Architecture
The separation of concerns in EpiMetal is achieved by the
common distinction between the presentation layer (front
end) and the data access layer (back end). Modern desktop
computers have considerable computing resources available,
and thanks to the developments in web browser JS engines
and web technologies, those resources can be fully appreci-
ated in web applications. The philosophy of EpiMetal is to
perform these calculations on the client side and store them
to the database for later retrieval. This is achieved by asyn-
chronously downloading chunks of the sample data and then
performing the computations as requested by the user.
Computationally heavy actions are processed in parallel using
Web Workers, if supported by the browser.
AngularJS was chosen as the front-end web framework
as it was popular at the time of starting the project, it had
an active user base and several useful libraries, and its two-
way data binding feature was appropriate considering the
interactive nature of the application.
Back and front ends
The back end is a Python script developed with a Flask
framework using Mongo Engine for object data mapping
and served with Gunicorn HTTP server. The back end
defines actions for retrieving the settings for the software,
the metadata for variables, and samples for the requested
variables. In addition, the back end is called to request pre-
viously stored SOM computations and SOM planes, and
to store new ones.
The front end is a single-page application written in JS
using AngularJS framework. Several open-source auxiliary
JS libraries are employed, most notably DC.js for interac-
tive charting throughout the application and Data-Driven
Documents (D3.js) as a dependency for DC.js and for
SOM planes and other chart types. Visual appearance and
user interface (UI) stylings depend on Bootstrap framework
and Angular-strap library. The UI allows the user to freely
create, resize, move and close window-like objects contain-
ing figures. The front end fetches necessary data samples
by querying the back end asynchronously as the user navi-
gates on the page.
Figures produced with EpiMetal can be exported either
in SVG or in PNG format. A particular state of the applica-
tion can always be saved by creating a link to it and shar-
ing the link with collaborators.
Usage exemplar: combined comprehensive
metabolomics and lipidomics data
We present here explorative analyses in a unique pilot co-
hort of 190 blood samples16–18 for which serum NMR
metabolomics3–6 and MS lipidomics8,19 data are available.
All these molecular data, including basic clinical character-
istics (age, sex, systolic and diastolic blood pressure, body
mass index and height) have been made open access along
with the EpiMetal software. The NMR metabolomics data
comprise over 200 metabolic measures, including standard
lipids, lipoprotein subclass and composition data, fatty
acids, amino acids, ketones, glycolysis and
gluconeogenesis-related substrates and an inflammatory
marker, glycoprotein acetyls.3–6 The MS lipidomics data
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consist of over 350 individual lipid concentrations in 20
lipid classes including, for example, ceramides, sphingo-
myelins, phosphatidylcholines, phosphatidylinositols, cho-
lesteryl esters and triacylglycerols.7,8,19 We used EpiMetal
to conduct a multifaceted exploratory analysis of this pilot
dataset. We sought to demonstrate some commonly known
epidemiological and molecular features of these types of
data.
First, we plotted the distribution of high-density lipo-
protein cholesterol (HDL-C) and the correlation of HDL-C
with triglycerides (TG) in the entire dataset (Figure 2B). As
expected, the histogram follows roughly a normal distribu-
tion. The scatterplot for HDL-C and TG association
reveals the well-known negative population-level
correlation.20
Figure 2. Explorative analysis of a cohort of 190 samples with serum NMR metabolomics and mass spectrometry lipidomics measures available. A:
The control panel of EpiMetal that contains clickable buttons for generating graphs and selecting, naming and generating subgroups. Colours indi-
cate the entire cohort (cyan) and selected subgroups based on the self-organizing map (SOM) analysis. B: The histograms of HDL-C in the entire co-
hort and in the subgroups and the scatterplot of HDL-C vs triglycerides. C: The SOM component planes for serum triglycerides, HDL-C and LDL-C
(note that the individuals in the entire cohort are identically distributed in each plane). Colours indicate high (red) and low (blue) concentration values
of the variable in each plane. Individuals with similar metabolic profiles cluster close to each other in the SOM component planes. The user can spec-
ify and select different subgroups via the circular selection tools. D: A box plot for LDL-C in the entire cohort and in the two subgroups. E: Regression
analyses with a forest plot showing standardized regression coefficients. Standardization means, that prior to analyses, all continuous, non-binary
variables are normalized to zero mean and unit standard deviation. Point estimates are indicated by a dot surrounded by 95% confidence interval (CI).
Plotting HDL-C as the outcome and triglycerides as an exposure illustrates the same negative association as already indicated via the scatterplot in B.
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We then applied the SOM analysis to organize the sam-
ples in the dataset via their systemic metabolic profiles.
Readers interested in the comparison of the SOM method-
ology with other subgrouping methods in epidemiology are
referred to a recent Software Application Profile in the
IJE.14 Additional details of the statistical issues in SOM
analyses can be found in references.10–13 We based the
SOM profiling on 26 metabolic measures including multi-
ple amino acids, 14 lipoprotein subclasses, standard
cholesterol measures, glycoprotein acetyls and glycolysis-
related measures. It should be noted that users could freely
modify the initial SOM training data according to their
preferences and data characteristics. The SOM planes for
low-density lipoprotein cholesterol (LDL-C), HDL-C and
TG are shown in Figure 2C. These planes reveal, on aver-
age, that people with high circulating HDL-C (circle A in
the SOM; subgroup marked lowest TG) are indeed those
that have low TG and vice versa (area marked B in the
SOM; subgroup marked lowest HDL), as expected by the
previous scatter plot. The SOM analysis also reveals that
circulating LDL-C concentrations are rather indifferent re-
garding HDL-C and TG in this pilot dataset; this is also
emphasized in Figure 2D by the box plot for LDL-C. These
associations can also be illustrated via formal regression
analyses; we considered HDL-C as an outcome variable
and LDL-C or TG as an exposure with age and sex as
covariates. The results are given in Figure 2E for the entire
cohort and the above-mentioned SOM-derived subgroups.
The negative association between HDL-C and TG,
depicted in Figure 2B, is well replicated in the formal re-
gression analysis. These demonstrations indicate the inter-
nal consistency of various software functions and illustrate
that the pilot cohort represents well-known features of li-
poprotein metabolism with respect to lipoprotein lipid
measures.
Exploration of associations between the NMR
metabolomics and MS lipidomics data can be found in
Supplementary Figure S2, available as Supplementary
data at IJE online, which shows a heatmap of
Spearman’s rank correlation coefficients between se-
lected lipoprotein (NMR) and lipid variables (MS).
Overall the correlations are very well in line with the
known molecular characteristics of lipoprotein sub-
classes and their lipid compositions21 and demonstrate
robust agreement between the NMR metabolomics and
MS lipidomics platforms.
To additionally demonstrate the properties of
EpiMetal, we performed an additional set of analyses using
data from two large-scale population-based epidemiologi-
cal cohorts including over 10 000 individuals (see the
Supplement, available as Supplementary data at IJE
online).
Conclusion
The new EpiMetal software is used via a modern web
browser and it provides an intuitive easy-to-use graphical
interphase for multiple statistical methods relevant in epi-
demiological analyses. It easily handles data for tens of
thousands of people and for hundreds of measures—num-
bers that are a reality nowadays in many metabolomics
applications. It provides instant data visualizations and
allows convenient sharing of results and data via data cap-
tures accessible via an automatically created www-link.
The datasets can be fully customized by the users. We illus-
trated the usage and opportunities of EpiMetal in real
large-scale epidemiological datasets (Figure 1; and the
Supplement, available as Supplementary data at IJE on-
line). In addition, we provide an open access usage exem-
plar of EpiMetal for a pilot cohort in which over 500
quantitative molecular measures are available from each
sample.
With increasing amounts of complex molecular data in
epidemiology, sophisticated software is required for both
convenient data handling and statistical analyses.
Without statistical or programming expertise, the learn-
ing curve to conveniently use typical modern data analy-
sis software, for example R,9 can be steep. From the
epidemiology perspective, extensive molecular data may
challenge traditional hypothesis-driven data analyses.
These are common situations in which the EpiMetal soft-
ware can help researchers. First, by enabling instant
graphical exploration and analyses of a (new) dataset
without the hurdles of programming-based data analyses;
and second, by also allowing data-driven options to find
unknown relations in the data without pre-existing hy-
potheses. As far as we are aware, the EpiMetal software
is a first-of-a-kind versatile tool for both traditional and
data-driven analyses of extensive large-scale epidemiolog-
ical datasets.
Supplementary data
Supplementary data are available at IJE online.
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